Clinical Trial Update: Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for allopurinol in patients with refractory angina across Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: Ministry of Health, Brazil | Conditions: Refractory Angina | Phase 2, Phase 3 | Status: UNKNOWN